Clinical Trial

Germline Testing for Predisposition to Myeloid Malignancies

Study acronym: MyeloGen
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this research study is to evaluate the feasibility of germline genetic testing using the investigational MyeloGen Gene Panel in adult participants diagnosed with myeloid malignancies.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-01.
Status change: Not Yet Recruiting → Recruiting 2026-04-21
Trial Details
NCT Number NCT07112287
Lead Sponsor Christopher Reilly
Collaborators: Broad Institute of MIT and Harvard
Conditions Myeloid Malignancy, Genetic Predisposition to Disease, Myeloid Hematological Malignancies
Enrollment 200 participants
Start Date 2025-11-10
Primary Completion 2030-04-01 (estimated)
Study Completion 2033-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-24